Revox 7

Revision Skincare

Revision Skincare Revox 7 is a professional-grade peptide serum built around a seven-peptide complex that targets both dynamic expression lines (like Botox-alternative peptides) and static wrinkles (collagen-stimulating signal peptides). The formulation includes Acetyl Hexapeptide-8 (Argireline) for SNARE-complex modulation, Palmitoyl Tripeptide-38 (SYN-TACKS) for dermal-epidermal junction proteins, and Dipeptide Diaminobutyroyl Benzylamide Diacetate (SYN-AKE) — a synthetic peptide that mimics the mechanism of Waglerin-1, a peptide from temple viper venom, to temporarily inhibit nicotinic acetylcholine receptors at the neuromuscular junction. The seven-peptide approach targets wrinkle formation at multiple points in the cascade: neuromuscular signaling (Argireline, SYN-AKE), extracellular matrix assembly (Matrixyl, SYN-TACKS), and surface texture (copper peptide fragments). This multi-mechanism strategy is supported by the brand's clinical testing showing 68% reduction in total wrinkle area after 8 weeks of twice-daily use (brand-sponsored, n=36). Revision Skincare products are typically distributed through dermatology practices and medical spas, positioning Revox 7 as a clinical alternative for patients who want Botox-adjacent topical support between injection appointments — or for those who prefer topical-only approaches.

Links to retailers are affiliate links. We may earn a commission on qualifying purchases at no extra cost to you.